Aminex Therapeutics Competitors and Similar CompaniesClear all
CureVac's competitors and similar companies include Puma Biotechnology and Celltrion Healthcare.
 Puma Biotechnology Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer. |  Celltrion Healthcare Celltrion Healthcare is a biopharmaceutical company specializing in oncology, influenza, psoriasis, and arthritis., | ||
Founding Date | Founding Date 2000 | Founding Date 2010 | Founding Date 2002 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US | Locations Los Angeles, US HQ | Locations Incheon, KR HQ |
Employees | Employees 82517% decrease | Employees 27214% decrease | Employees 6301% increase |
Valuation ($) | Valuation ($) 648.3 m | Valuation ($) 136.8 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) €535.2m (FY, 2024) | Revenue (est.) $228.4m (FY, 2025) | Revenue (est.) ₩2t (FY, 2022) |
Cost of goods | Cost of goods €9.7m (FY, 2024) | Cost of goods $58.2m (FY, 2025) | Cost of goods ₩1.4t (FY, 2022) |
Gross profit | Gross profit €534.4m (FY, 2024) | Gross profit $170.2m (FY, 2025) | Gross profit ₩664.7b (FY, 2022) |
Net income | Net income €162.2m (FY, 2024) | Net income N/A | Net income ₩147.2b (FY, 2022) |
Funding | |||
Total funding raised | Total funding raised $ 1.1b | Total funding raised $ 172m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Puma Biotechnology
HQ
Los Angeles, US
Employees
272↓ 14% decrease
Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.
View companyCelltrion Healthcare
HQ
Incheon, KR
Employees
630↑ 1% increase
Celltrion Healthcare is a biopharmaceutical company specializing in oncology, influenza, psoriasis, and arthritis.,
View company